Dr. Panther is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Technology Square
Cambridge, MA 02139
Education & Training
- University of WashingtonFellowship, Infectious Disease, 1990 - 1993
- University of California (San Francisco)Residency, Internal Medicine, 1986 - 1990
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1986
Certifications & Licensure
- MA State Medical License 1994 - 2022
Publications & Presentations
PubMed
- 2 citationsCharacterization of humoral and cellular immunologic responses to an mRNA-based human cytomegalovirus vaccine from a phase 1 trial of healthy adults.Kai Wu, Yixuan Jacob Hou, Dan Makrinos, Runxia Liu, Alex Zhu
Journal of Virology. 2024-04-16 - 5 citationsSafety and Immunogenicity of a Messenger RNA-Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial.Carlos Fierro, Daniel Brune, Marian Shaw, Howard Schwartz, Conor Knightly
The Journal of Infectious Diseases. 2024-09-23 - 18 citationsSafety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults.Allison August, Christine A Shaw, Heather Lee, Conor Knightly, Shiva Kalidindia
Open Forum Infectious Diseases. 2022-07-01
Press Mentions
- Investigational Vaccine Targeting CMV, the #1 Infectious Cause of Birth Defects in the U.S.June 3rd, 2022
- Pursuing Victory: Moderna Begins Dosing in Phase III CMV TrialNovember 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: